Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001199101 | SCV001370096 | likely pathogenic | Congenital dyserythropoietic anemia, type II | 2016-01-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PM2,PM3,PP3,PP4,PP5. |
Institute of Human Genetics, |
RCV001199101 | SCV002578015 | likely pathogenic | Congenital dyserythropoietic anemia, type II | 2022-08-22 | criteria provided, single submitter | clinical testing | ACMG categories: PM1,PM2,PP3,PP5 |
Labcorp Genetics |
RCV002559272 | SCV003443772 | uncertain significance | Congenital dyserythropoietic anemia, type II; Cowden syndrome 7 | 2022-08-07 | criteria provided, single submitter | clinical testing | This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 239 of the SEC23B protein (p.Asp239Gly). This variant is present in population databases (rs761034212, gnomAD 0.003%). This missense change has been observed in individual(s) with dyserythropoietic anemia (PMID: 19561605, 33159567). ClinVar contains an entry for this variant (Variation ID: 932011). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C15"). Experimental studies have shown that this missense change does not substantially affect SEC23B function (PMID: 19561605). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |